Literature DB >> 21368732

Subclinical atherosclerosis and genetic risk markers in healthy offspring of patients with premature myocardial infarction.

S Barra1, S Scala, V Cuomo, P Guarini, D Colaizzo, M Margaglione, C Materazzi, G Vitagliano, G Gaeta, A Faiella.   

Abstract

AIM: Healthy young subjects with parental history of premature myocardial infarction (PHPMI) might constitute a privileged population for the study of genetic risk markers (GRM) for atherosclerosis. Aim of this study was to evaluate which, if any, GRM atherosclerosis-associated in previous studies has increased prevalence in a selected population.
METHODS: Twenty-four healthy young subjects (12 males and 12 females; mean age 18.0±8.0 years) with PHPMI and 24 age- (±1 year), sex-matched healthy subjects without PHPMI were enrolled in the study. They underwent: 1) fasting measurement of lipid profile, resting blood pressure and body mass index; 2) high resolution B-mode ultrasonographic evaluation of common carotid artery intima-media thickness (IMT); 3) evaluation of Single Nucleotide Polymorphisms (SNPs) for six candidate genes associated with preclinical atherosclerosis.
RESULTS: Compared to controls, subjects with PHPMI had increased IMT of common carotid arteries (mean of combined sites: 0.535±0.171 mm versus 0.432± 0.133 mm in controls, P=0.017). Offspring of coronary patients showed an increased prevalence of the unfavourable chemochine (C-X-C motif) ligand 12 (CXCL12) SNP risk genotype (P=0.047).
CONCLUSION: In healthy young subjects with PHPMI there is an increased prevalence of the unfavorable CXCL12 SNP risk genotype.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21368732

Source DB:  PubMed          Journal:  Minerva Cardioangiol        ISSN: 0026-4725            Impact factor:   1.347


  1 in total

1.  Carotid intima-media thickness in young survivors of acute myocardial infarction.

Authors:  Aleš Linhart; Gabriela Dostálová; Jan Bělohlávek; Libor Vítek; Debora Karetová; Michaela Ingrischová; Kristina Bojanovská; Pavel Poláček; Regina Votavová; Renata Cífková
Journal:  Exp Clin Cardiol       Date:  2012
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.